Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Patient Information Leaflet last updated on the eMC: 18/05/2011
PIL Madopar CR Capsules 125

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 13/08/2009 and displayed until 18/05/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 24/09/2007 and displayed until 13/08/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 24/08/2007 and displayed until 24/09/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/05/2006 and displayed until 24/08/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 24/02/2003 and displayed until 22/05/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 02/10/2001 and displayed until 24/02/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 14/08/2000 and displayed until 02/10/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   levodopa
   benserazide hydrochloride